Vestcor Inc has significantly increased its stake in Maximus, Inc., a prominent health services provider, by a notable 2.3% during the first quarter. This strategic move expanded Vestcor Inc’s ownership to 9,877 shares, an acquisition that added 223 shares to their portfolio. At the close of the most recent reporting period, the total value of Vestcor Inc’s holdings in Maximus stood impressively at $674,000, underscoring a strong commitment to the company’s prospects.
This substantial investment by Vestcor Inc is part of a broader trend among large institutional investors actively adjusting their positions in Maximus. UMB Bank n.a., for instance, dramatically boosted its stake by 70.2% in the first quarter, now holding 606 shares valued at $41,000 after acquiring an additional 250 shares. Such movements by financial institutions often signal a collective confidence in a company’s market standing and future performance.
Further demonstrating this institutional interest, GAMMA Investing LLC increased its holdings in Maximus shares by 67.1% during the same period, bringing their total to 732 shares worth $50,000. Even more remarkably, NBC Securities Inc. executed an astounding 114,900.0% increase in their Maximus stock position, now owning 1,150 shares valued at $78,000, illustrating aggressive portfolio restructuring in anticipation of growth.
Blue Trust Inc. also contributed to the escalating institutional ownership, lifting its stake by 32.8% in the first quarter. This adjustment resulted in their current holding of 1,228 shares, valued at $84,000, following the acquisition of an additional 303 shares. These consecutive boosts from various firms highlight the perceived stability and potential upside of Maximus, Inc. within the health services sector.
The company’s stock performance reflects a steady trajectory, with Maximus, Inc. opening at $72.84 on a recent Friday. Its 50-day moving average stands at $71.31, while the 200-day moving average is slightly lower at $70.50, indicating consistent price movement. With a robust market capitalization of $4.10 billion and a P/E ratio of 14.48, Maximus presents a compelling profile for investors seeking solid returns.
From a financial health perspective, Maximus, Inc. maintains a debt-to-equity ratio of 0.87, coupled with strong liquidity metrics: a current ratio of 1.84 and an identical quick ratio of 1.84. These figures collectively suggest a company with manageable debt levels and ample capacity to cover its short-term obligations, reinforcing its financial resilience in a dynamic market.
Adding to its appeal, Maximus recently declared a quarterly dividend of $0.30 per share, payable on Sunday, August 31st, to investors of record by Friday, August 15th. This translates to an annualized dividend of $1.20, offering a yield of 1.6%. The company’s dividend payout ratio (DPR) currently stands at 23.86%, signaling a balanced approach to rewarding shareholders while retaining earnings for growth.
In other significant corporate developments, a director of Maximus sold 7,913 shares of the company’s stock on Friday, May 30th, in a transaction valued at $572,742.94 at an average price of $72.38 per share. Following this sale, the director’s remaining holdings amounted to 14,205 shares, worth approximately $1,028,157.90. Such insider transactions, disclosed in SEC filings, provide crucial insights into management’s perception of the company’s value.
Maximus, Inc. operates as a key provider of government services, spanning operations across the United States and internationally through three distinct segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment, for example, is instrumental in offering program eligibility support, managing customer contact centers, and facilitating health plan choice counseling, showcasing the company’s broad impact on public welfare programs.
